Up next

Autoplay

ADA: FDA Unlikely to Zap Pioglitazone

0 Views • 08/25/25
Share
Side Effects
Side Effects
Subscribers
0

SAN DIEGO -- Bladder cancer risks aren't likely to send the diabetes drug pioglitazone (Actos) down the same path as rosiglitazone (Avandia), according to this exclusive InFocus report from the American Diabetes Association meeting.

Medpage Today: http://medpagetoday.com
Online CME - Continuing medical education: http://www.medpagetoday.com/cme/
Latest medical news: http://www.medpagetoday.com/latest/

The MedPage Today app:
iOS: https://goo.gl/JKrkHq
Android: https://play.google.com/store/....apps/details?id=com.

MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageToday
Medpage Today on Facebook: https://www.facebook.com/MedPageToday

Show more
0 Comments sort Sort By

Up next

Autoplay